Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Etentalin, Ahura Hyperactive, and Risperidone Syrups in Preschool Children With ADHD
IRCT20160530028182N9Phase 2Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of risperidone in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Kurdistan University of Medical Sciences. Started Apr 2022; status: completed.
02
Drugs
risperidone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20160530028182N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160530028182N9.